全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

RNA解旋酶DDX5在癌症中的研究进展
Advances in the Study of RNA Deconjugating Enzyme DDX5 in Cancer

DOI: 10.12677/wjcr.2025.153016, PP. 124-131

Keywords: DDX5,结构与功能,癌症
DDX5
, Structure and Function, Cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

恶性肿瘤是威胁人类健康的重大疾病之一,由于肿瘤的异质性和发病机理的复杂性,临床治疗面临巨大挑战。因此,寻找精准的治疗靶点和新型分子标志物已成为肿瘤学研究热点。DDX5 (DEAD-box RNA helicase 5)是DEAD-box蛋白家族的重要成员,在进化上高度保守,主要通过ATP依赖的RNA解旋活性参与多种基因表达调控。研究表明,DDX5在多种癌症中异常表达。因此,深入探究DDX5在癌症发生发展中的调控机制,成为当前癌症研究领域的热点。本论文综述了DDX5蛋白的结构特征及其在转录调节、细胞周期调控和DNA损伤修复等基础生物学过程中的关键作用,重点探讨DDX5通过调控细胞周期、转录因子活性及上皮–间质细胞转化等机制影响多种癌症的发生发展,为进一步研究DDX5作为潜在治疗靶点和预后标志物提供指导。
Malignant tumors are one of the major diseases threatening human health, and clinical treatment faces great challenges due to the heterogeneity of tumors and the complexity of their pathogenesis. Therefore, the search for precise therapeutic targets and novel molecular markers has become a hot spot in oncology research. DDX5 (DEAD-box RNA helicase 5) is an important member of the DEAD-box protein family, which is highly conserved evolutionarily and is involved in the regulation of a wide range of gene expression mainly through ATP-dependent RNA unwinding activity. Studies have shown that DDX5 is aberrantly expressed in a variety of cancers. Therefore, in-depth investigation into the regulatory mechanisms of DDX5 in cancer development and progression has become a major focus in current cancer research. This review summarizes the structural characteristics of the DDX5 protein and its crucial roles in fundamental biological processes including transcriptional regulation, cell cycle control, and DNA damage repair. With a focus on oncogenesis mechanisms, the paper specifically examines how DDX5 influences cancer development and progression through regulating cell cycle dynamics, transcription factor activity, and epithelial-mesenchymal transition (EMT). These comprehensive analyses provide valuable insights for future investigations targeting DDX5 as a potential therapeutic target and prognostic biomarker in cancer research.

References

[1]  Luo, Q., Liu, P., Yu, P. and Qin, T. (2023) Cancer Stem Cells Are Actually Stem Cells with Disordered Differentiation: The Monophyletic Origin of Cancer. Stem Cell Reviews and Reports, 19, 827-838.
https://doi.org/10.1007/s12015-023-10508-2
[2]  Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., et al. (2024) Cancer Incidence and Mortality in China, 2022. Journal of the National Cancer Center, 4, 47-53.
https://doi.org/10.1016/j.jncc.2024.01.006
[3]  Han, L., Meng, Y. and Jianguo, Z. (2024) Research Progress of PD 1/PD L1 Inhibitors in the Treatment of Urological Tumors. Current Cancer Drug Targets, 24, 1104-1115.
https://doi.org/10.2174/0115680096278251240108152600
[4]  Zhao, M., Zhang, Y., Miao, J., Zhou, H., Jiang, Y., Zhang, Y., et al. (2023) An Activatable Phototheranostic Probe for Anti‐hypoxic Type I Photodynamic‐ and Immuno-Therapy of Cancer. Advanced Materials, 36, Article 2305243.
https://doi.org/10.1002/adma.202305243
[5]  Yin, W., Wang, J., Jiang, L. and James Kang, Y. (2021) Cancer and Stem Cells. Experimental Biology and Medicine, 246, 1791-1801.
https://doi.org/10.1177/15353702211005390
[6]  Nyamao, R.M., Wu, J., Yu, L., Xiao, X. and Zhang, F. (2019) Roles of DDX5 in the Tumorigenesis, Proliferation, Differentiation, Metastasis and Pathway Regulation of Human Malignancies. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1871, 85-98.
https://doi.org/10.1016/j.bbcan.2018.11.003
[7]  Li, F., Fountzilas, C., Puzanov, I., et al. (2021) Multiple Functions of the DEAD-Box RNA Helicase, DDX5 (p68), Make DDX5 a Superior Oncogenic Biomarker and Target for Targeted Cancer Therapy. American Journal of Cancer Research, 11, 5190-5213.
[8]  Li, F., Ling, X., Chakraborty, S., Fountzilas, C., Wang, J., Jamroze, A., et al. (2023) Role of the Dead-Box RNA Helicase DDX5 (p68) in Cancer DNA Repair, Immune Suppression, Cancer Metabolic Control, Virus Infection Promotion, and Human Microbiome (Microbiota) Negative Influence. Journal of Experimental & Clinical Cancer Research, 42, Article No. 213.
https://doi.org/10.1186/s13046-023-02787-x
[9]  Tabassum, S. and Ghosh, M.K. (2023) Dead-Box RNA Helicases with Special Reference to P68: Unwinding Their Biology, Versatility, and Therapeutic Opportunity in Cancer. Genes & Diseases, 10, 1220-1241.
https://doi.org/10.1016/j.gendis.2022.02.008
[10]  Dai, T., Cao, L., Yang, Z., Li, Y., Tan, L., Ran, X., et al. (2014) P68 RNA Helicase as a Molecular Target for Cancer Therapy. Journal of Experimental & Clinical Cancer Research, 33, Article No. 64.
https://doi.org/10.1186/s13046-014-0064-y
[11]  Dardenne, E., Polay Espinoza, M., Fattet, L., Germann, S., Lambert, M., Neil, H., et al. (2014) RNA Helicases DDX5 and DDX17 Dynamically Orchestrate Transcription, Mirna, and Splicing Programs in Cell Differentiation. Cell Reports, 7, 1900-1913.
https://doi.org/10.1016/j.celrep.2014.05.010
[12]  Zheng, G., Zhu, Y., Xu, L., Chen, S., Zhang, X., Li, W., et al. (2023) LncRNA MACC1-AS1 Associates with DDX5 to Modulate MACC1 Transcription in Breast Cancer Cells. iScience, 26, Article 107642.
https://doi.org/10.1016/j.isci.2023.107642
[13]  Lan, H., Lin, C. and Yuan, H. (2022) Knockdown of KRAB Domain-Associated Protein 1 Suppresses the Proliferation, Migration and Invasion of Thyroid Cancer Cells by Regulating P68/DEAD Box Protein 5. Bioengineered, 13, 11945-11957.
https://doi.org/10.1080/21655979.2022.2067289
[14]  Cao, J., Wang, J., Shi, B., et al. (2024) DDX5-Targeting Fragile X Mental Retardation Protein Regulates the WNT/β-Catenin Signaling Pathway to Promote Epithelial Mesenchymal Transition in Breast Cancer. Journal of Sichuan University Medical Science Edition, 55, 1138-1149.
[15]  Li, Z., Kim, W., Utturkar, S., Yan, B., Lanman, N.A., Elzey, B.D., et al. (2024) DDX5 Deficiency Drives Non-Canonical NF-κB Activation and NRF2 Expression, Influencing Sorafenib Response and Hepatocellular Carcinoma Progression. Cell Death & Disease, 15, Article No. 583.
https://doi.org/10.1038/s41419-024-06977-z
[16]  Nicol, S.M., Bray, S.E., Derek Black, H., Lorimore, S.A., Wright, E.G., Lane, D.P., et al. (2013) The RNA Helicase P68 (DDX5) Is Selectively Required for the Induction of p53-Dependent p21 Expression and Cell-Cycle Arrest after DNA Damage. Oncogene, 32, 3461-3469.
https://doi.org/10.1038/onc.2012.426
[17]  Yu, Z., Mersaoui, S.Y., Guitton-Sert, L., Coulombe, Y., Song, J., Masson, J., et al. (2020) DDX5 Resolves R-Loops at DNA Double-Strand Breaks to Promote DNA Repair and Avoid Chromosomal Deletions. NAR Cancer, 2, zcaa028.
https://doi.org/10.1093/narcan/zcaa028
[18]  Wen, C., Cao, L., Wang, S., Xu, W., Yu, Y., Zhao, S., et al. (2024) MCM8 Interacts with DDX5 to Promote R-Loop Resolution. The EMBO Journal, 43, 3044-3071.
https://doi.org/10.1038/s44318-024-00134-0
[19]  Xu, C.M., Chen, L.X., Gao, F., et al. (2019) miR-431 Suppresses Proliferation and Metastasis of Lung Cancer via down-Regulating DDX5. European Review for Medical and Pharmacological Sciences, 23, 699-707.
[20]  Fuller-Pace, F.V. (2013) DEAD Box RNA Helicase Functions in Cancer. RNA Biology, 10, 121-132.
https://doi.org/10.4161/rna.23312
[21]  Wang, Z., Luo, Z., Zhou, L., Li, X., Jiang, T. and Fu, E. (2015) DDX5 Promotes Proliferation and Tumorigenesis of Non-Small-Cell Lung Cancer Cells by Activating β-Catenin Signaling Pathway. Cancer Science, 106, 1303-1312.
https://doi.org/10.1111/cas.12755
[22]  Xing, Z., Russon, M.P., Utturkar, S.M. and Tran, E.J. (2020) The RNA Helicase DDX5 Supports Mitochondrial Function in Small Cell Lung Cancer. Journal of Biological Chemistry, 295, 8988-8998.
https://doi.org/10.1074/jbc.ra120.012600
[23]  Zhang, Y., Ye, S., Lu, W., Zhong, J., Leng, Y., Yang, T., et al. (2023) RNA Helicase Dead-Box Protein 5 Alleviates Nonalcoholic Steatohepatitis Progression via Tethering TSC Complex and Suppressing mTORC1 Signaling. Hepatology, 77, 1670-1687.
https://doi.org/10.1002/hep.32651
[24]  Fu, P., Lin, L., Zhou, H., Zhao, S. and Jie, Z. (2021) Circular RNA circEGFR Regulates Tumor Progression via the miR-106a-5p/DDX5 Axis in Colorectal Cancer. Brazilian Journal of Medical and Biological Research, 54, e10940.
https://doi.org/10.1590/1414-431x2020e10940
[25]  Wang, X., Yang, P., Zhang, D., Lu, M., Zhang, C. and Sun, Y. (2021) LncRNA SNHG14 Promotes Cell Proliferation and Invasion in Colorectal Cancer through Modulating miR-519b-3p/DDX5 Axis. Journal of Cancer, 12, 4958-4970.
https://doi.org/10.7150/jca.55495
[26]  Tabassum, S., Basu, M. and Ghosh, M.K. (2023) The Dead-Box RNA Helicase DDX5 (p68) and β-Catenin: The Crucial Regulators of FOXM1 Gene Expression in Arbitrating Colorectal Cancer. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, 1866, Article 194933.
https://doi.org/10.1016/j.bbagrm.2023.194933
[27]  Wang, R., Jiao, Z., Li, R., Yue, H. and Chen, L. (2012) P68 RNA Helicase Promotes Glioma Cell Proliferation in Vitro and in Vivo via Direct Regulation of NF-κB Transcription Factor P50. Neuro-Oncology, 14, 1116-1124.
https://doi.org/10.1093/neuonc/nos131
[28]  Wang, R., Bao, H., Du, W., Chen, X., Liu, H., Han, D., et al. (2018) P68 RNA Helicase Promotes Invasion of Glioma Cells through Negatively Regulating DUSP5. Cancer Science, 110, 107-117.
https://doi.org/10.1111/cas.13858
[29]  Gómez-González, B., Sessa, G., Carreira, A. and Aguilera, A. (2021) A New Interaction between BRCA2 and DDX5 Promotes the Repair of DNA Breaks at Transcribed Chromatin. Molecular & Cellular Oncology, 8, Article 1910474.
https://doi.org/10.1080/23723556.2021.1910474
[30]  Taniguchi, T., Iizumi, Y., Watanabe, M., Masuda, M., Morita, M., Aono, Y., et al. (2016) Resveratrol Directly Targets DDX5 Resulting in Suppression of the MTORC1 Pathway in Prostate Cancer. Cell Death & Disease, 7, e2211.
https://doi.org/10.1038/cddis.2016.114
[31]  Du, C., Li, D., Li, N., Chen, L., Li, S., Yang, Y., et al. (2017) DDX5 Promotes Gastric Cancer Cell Proliferation in Vitro and in Vivo through mTOR Signaling Pathway. Scientific Reports, 7, Article No. 42876.
https://doi.org/10.1038/srep42876
[32]  Liu, C., Wang, L., Jiang, Q., Zhang, J., Zhu, L., Lin, L., et al. (2019) Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin. Frontiers in Oncology, 9, Article 211.
https://doi.org/10.3389/fonc.2019.00211
[33]  Shao, Y., Li, H., Wu, Y., Wang, X., Meng, J., Hu, Z., et al. (2023) The Feedback Loop of AURKA/DDX5/TMEM147-AS1/let-7 Drives Lipophagy to Induce Cisplatin Resistance in Epithelial Ovarian Cancer. Cancer Letters, 565, Article 216241.
https://doi.org/10.1016/j.canlet.2023.216241
[34]  Mao, Y., Yang, D., He, J. and Krasna, M.J. (2016) Epidemiology of Lung Cancer. Surgical Oncology Clinics of North America, 25, 439-445.
https://doi.org/10.1016/j.soc.2016.02.001
[35]  Zulfiqar, B., Farooq, A., Kanwal, S. and Asghar, K. (2022) Immunotherapy and Targeted Therapy for Lung Cancer: Current Status and Future Perspectives. Frontiers in Pharmacology, 13, Article 1035171.
https://doi.org/10.3389/fphar.2022.1035171
[36]  Zou, G. and Park, J. (2023) Wnt Signaling in Liver Regeneration, Disease, and Cancer. Clinical and Molecular Hepatology, 29, 33-50.
https://doi.org/10.3350/cmh.2022.0058
[37]  Huang, D.Q., El-Serag, H.B. and Loomba, R. (2020) Global Epidemiology of NAFLD-Related HCC: Trends, Predictions, Risk Factors and Prevention. Nature Reviews Gastroenterology & Hepatology, 18, 223-238.
https://doi.org/10.1038/s41575-020-00381-6
[38]  Powell, E.E., Wong, V.W. and Rinella, M. (2021) Non-Alcoholic Fatty Liver Disease. The Lancet, 397, 2212-2224.
https://doi.org/10.1016/s0140-6736(20)32511-3
[39]  Zunica, E.R.M., Heintz, E.C., Axelrod, C.L. and Kirwan, J.P. (2022) Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers, 14, Article 4051.
https://doi.org/10.3390/cancers14164051
[40]  He, R., Huang, S., Lu, J., Su, L., Gao, X. and Chi, H. (2024) Unveiling the Immune Symphony: Decoding Colorectal Cancer Metastasis through Immune Interactions. Frontiers in Immunology, 15, Article 1362709.
https://doi.org/10.3389/fimmu.2024.1362709
[41]  Li, N., Lu, B., Luo, C., Cai, J., Lu, M., Zhang, Y., et al. (2021) Incidence, Mortality, Survival, Risk Factor and Screening of Colorectal Cancer: A Comparison among China, Europe, and Northern America. Cancer Letters, 522, 255-268.
https://doi.org/10.1016/j.canlet.2021.09.034
[42]  Wang, Z., Dan, W., Zhang, N., Fang, J. and Yang, Y. (2023) Colorectal Cancer and Gut Microbiota Studies in China. Gut Microbes, 15, Article 2236364.
https://doi.org/10.1080/19490976.2023.2236364
[43]  Zou, S., Qin, B., Yang, Z., Wang, W., Zhang, J., Zhang, Y., et al. (2022) CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer. Cancer Research, 83, 414-427.
https://doi.org/10.1158/0008-5472.can-22-2145
[44]  Sun, Y., Wang, Z. and Zhou, D. (2013) Long Non-Coding RNAs as Potential Biomarkers and Therapeutic Targets for Gliomas. Medical Hypotheses, 81, 319-321.
https://doi.org/10.1016/j.mehy.2013.04.010
[45]  Zottel, A., Šamec, N., Videtič Paska, A. and Jovčevska, I. (2020) Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs. Cancers, 12, Article 1842.
https://doi.org/10.3390/cancers12071842
[46]  Zubair, M., Wang, S. and Ali, N. (2021) Advanced Approaches to Breast Cancer Classification and Diagnosis. Frontiers in Pharmacology, 11, Article 632079.
https://doi.org/10.3389/fphar.2020.632079
[47]  Giaquinto, A.N., Sung, H., Miller, K.D., Kramer, J.L., Newman, L.A., Minihan, A., et al. (2022) Breast Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 524-541.
https://doi.org/10.3322/caac.21754
[48]  Kost, G.C., Yang, M.Y., Li, L., Zhang, Y., Liu, C., Kim, D.J., et al. (2015) A Novel Anti-Cancer Agent, 1‐(3,5-Dimethoxyphenyl)-4-[(6-Fluoro-2-Methoxyquinoxalin-3-yl)Aminocarbonyl] Piperazine (RX‐5902), Interferes with β-Catenin Function through Y593 Phospho-p68 RNA Helicase. Journal of Cellular Biochemistry, 116, 1595-1601.
https://doi.org/10.1002/jcb.25113
[49]  Ling, X., Wu, W., Yan, L., Curtin, L., Farrauto, M.M., Sexton, S., et al. (2024) Clinically and Orally Compatible Formulation-Manufactured DDX5 (p68)-Targeting Molecular Glue FL118 Products Exhibit Low Toxicity but High Efficacy against Human Cancer. Journal of Pharmaceutical Analysis, 14, Article 101001.
https://doi.org/10.1016/j.jpha.2024.101001
[50]  Mao, X., Guo, S., Gao, L. and Li, G. (2021) Circ-XPR1 Promotes Osteosarcoma Proliferation through Regulating the miR-214-5p/DDX5 Axis. Human Cell, 34, 122-131.
https://doi.org/10.1007/s13577-020-00412-z

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133